Age-related changes in parathyroid hormone-related protein and vascular endothelial growth factor in human osteoblastic cells

Osteoporosis International

Volumn 13, Issue 11, 2002, Pages 874-881

  Martinez P ^a   Esbrit, P ^b   Rodrigo, A ^a   Alvarez Arroyo, M V ^c   Martinez M E ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b Bone and Mineral Metab Laboratory   (Spain)

^c Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

Aging; Human osteoblastic cells; Parathyroid hormone related protein; Skeletal site; Vascular endothelial growth factor

Indexed keywords

CALCITRIOL; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PARATHYROID HORMONE RELATED PROTEIN; VASCULOTROPIN;

ADULT; AGED; AGING; ARTICLE; CELL ISOLATION; CELL STIMULATION; EXPLANT; FEMALE; HORMONE RELEASE; HUMAN; HUMAN CELL; IMMUNORADIOMETRIC ASSAY; MALE; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; TRABECULAR BONE;

ADULT; AGED; AGED, 80 AND OVER; AGING; CELL CULTURE TECHNIQUES; ENDOTHELIAL GROWTH FACTORS; FEMALE; HIP JOINT; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KNEE JOINT; LYMPHOKINES; MALE; MIDDLE AGED; OSTEOBLASTS; PARATHYROID HORMONE-RELATED PROTEIN; PEPTIDE HORMONES; RNA, MESSENGER; STEROID HYDROXYLASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036853422     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001980200120     Document Type: Article

References (40)

1. Trueta J. The role of the vessels in osteogenesis. J Bone Joint Surg 1963;45:402-18.
2. Streeten EA. Biology of bone endothelial cells. Bone Miner 1990;10:85-94.
3. Gerber H-P, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999;5:623-8.
4. Brighton CT. Structure and function of the growth plate. Clin Orthop Rel Res 1978;136:22-32.
5. Rivard A, Fabre JE, Silver M, Chen D, Murohara T, Kearney M, et al. Age-dependent impairment of angiogenesis. Circulation 1999;99:111-20.
6. Reed MJ, Corsa A, Pendergrass W, Penn P, Sage EH, Abrass IB. Neovascularization in aged mice: Delayed angiogenesis is coincident with decreased levels of transforming growth factor betal and type I collagen. Am J Pathol 1998;152:113-23.
7. Burkhardt B, Kettner G, Bohm W, Schmidmeier M, Schlag R, Frish B, et al. Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: A comparative histomorphometric study. Bone 1987;8:157-64.
8. Reeve J, Arlot M, Wootton R, Edouard C, Tellez M, Hesp R, et al. Skeletal blood flow, iliac histomorphometry, and strontium kinetics in osteoporosis: A relationship between blood flow and corrected apposition rate. J Clin Endocrinol 1988;66:1124-31.
9. Philbrick WM, Wysolmerski JJ, Galbraith S, Holt E, Orloff JJ, Yang KH, et al. Defining the roles of parathyroid hormone-related protein in normal physiology. Physiol Rev 1996;76:123-73.
10. Strewler GJ. The physiology of parathyroid hormone-related protein. N Engl J Med 2000;342:177-85.
11. Lanske B, Amling M, Neff L, Guiducci J, Baron R, Kronenberg HM. Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development. J Clin Invest 1999;104: 399-407.
12. 3 in human osteoblast-like cells. J Bone Miner Res 1996;11:472-79.
13. 3 induces the expression of vascular endothelial growth factor in osteoblastic cells. Endocr Res 1997;23:213-29.
14. Esbrit P, Alvarez-Arroyo MV, De Miguel F, Martin O, Martinez ME, Caramelo C. C-terminal parathyroid hormone-related protein increases vascular endothelial growth factor in human osteoblastic cells. J Am Soc Nephrol 2000; 11: 1085-92.
15. Ishikawa M, Ouchi Y, Akishita M, Kozaki K, Toba K, Namiki A, et al. Age-related decrease in the effect of parathyroid hormone- related protein on cytosolic free calcium level and tension in aortic smooth muscle. Naunyn Schmiedebergs Arch Pharmacol 1995; 351:517-22.
16. Pfeilschifter J, Diel I, Pilz U, Brunotte K, Naumann A, Ziegler R. Mitogenic responsiveness of human bone cells in vitro to hormones and growth factors decreases with age. J Bone Miner Res 1993;8:707-17.
17. Owei Liu X, Lin C-S, Graziottin T, Resplande J, Lue TF. Vascular endothelial growth factor promotes proliferation and migration of cavernous smooth muscle cells. J Urol 2001;166:354-60.
18. Kang DH, Anderson S, Kim YG, Mazzalli M, Suga S, Jefferson JA, et al. Impaired angiogenesis in the aging kidney: Vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis 2001;37:601-11.
19. Street J, Wang JH, Wakai A, McGuinness A, Redmond HP. The angiogenic response to skeletal injury is preserved in the elderly [abstract]. 46th Annual Meeting of the American Orthopaedic Research Society, Orlando, FL, 2000:306.
20. Himeno W. Angiogenic growth factor in patients with cyanotic congenital heart disease and in normal children. Kurume Med 2001;48:111-6.
21. Oehler MK, Caffier H. Prognostic relevance of serum vascular endothelial growth factor in ovarian cancer. Anticancer Res 2000;20:5109-12.
22. Selgas R, Del Peso G, Bajo MA, Castro MA, Molina S, Cirugeda A, et al. Spontaneous VEGF production by cultured peritoneal mesothelial cells from patients on peritoneal dialysis. Perit Dial Int 2000;20:798-801.
23. Owen TA, Aronow MS, Barone LM, Bettencourt B, Stein GS, Lian JB. Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: Dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology 1991;128:1496-504.
24. 3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblast and by growth factors produced by endothelial cells. Endocrinology 1997; 138:2953-62.
25. 3 on gene expression and secretion. J Clin Invest 1991;87:884-93.
26. 3-mediated transcriptional repression. Mol Endocrinol 1996;10:672-81.
27. Dawson-Hughes B, Dallal GE, Krall EA, Harris S, Sokoll LJ, Falconer G. Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Intern Med 1991;115:505-12.
28. Martínez ME, Del Campo MT, Medina S, Sánchez M, Sanchez-Cabezudo MJ, Esbrit P, et al. Influence of skeletal site of origin and donor age on osteoblastic cell growth and differentiation. Calcif Tissue Int 1999;64:280-6.
29. 3-induced response of various osteoblastic markers in human osteoblastic cells. Bone 1999;24:203-9.
30. 3 stimulation, and in basal VDR expression, in human osteoblastic cells, according to donor age and skeletal origin. Bone 2001;29:35-41.
31. De Miguel F, Motellón JL, Hurtado J, Jiménez FJ, Esbrit P. Comparison of two immunoradiometric assays for parathyroid hormone-related protein in the evaluation of cancer patients with and without hypercalcemia. Clin Chim Acta 1998;277:171-80.
32. Winet H. The role of microvasculature in normal and perturbed bone healing as revealed by intravital microscopy. Bone 1996;19:S39-57.
33. Harada S-I, Nagy JA, Sullivan KA, Thomas KA, Endo N, Rodan GA, et al. Induction on vascular endothelial growth factor expression by prostaglandin E2 and El in osteoblast. J Clin Invest 1994;93:2490-6.
34. Suda N, Gillispie MT, Traianedes K, Zhou H, Ho PWM, Hards DK, et al. Expression of parathyroid hormone-related protein in cells of osteoblast lineage. J Cell Physiol 1996;166:94-104.
35. Claffey KP, Wilkison WD, Spiegelman BM. Vascular endothelial growth factor: Regulation by cell differentiation and activated second messenger pathways. J Biol Chem 1992;267:16317-22.
36. Deckers MM, Karperien M, Van der Bent C, Yamashita T, Papapoulus SE, Lowik CW. Expression of vascular endothelial growth factor and their receptors during osteoblast differentiation. Endocrinology 2000;141:1667-74.
37. Hock JM, Krishnan V, Onyia JE, Bidwell JP, Milas J, Stanislaus D. Osteoblast apoptosis and bone turnover. J Bone Miner Res 2001;16:975-84.
38. Miao D, Tong XK, Chan GK, Panda D, McPherson PS, Goltzman D. Parathyroid hormone-related peptide stimulates osteogenic cell proliferation through protein kinase C activation of the Ras/ mitogen-activated protein kinase signaling pathway. J Biol Chem 2001;276:32204-13.
39. Street JT, Wakai A, Wang JH, Wu QD, McGuinness A, Redmond HP. Vascular endothelial growth factor - Osteoblast survival factor [abstract]. 47th Annual Meeting of the American Orthopaedic Research Society, San Francisco, CA, 2001:485.
40. 3 inhibits angiogenesis in vitro and in vivo. Circ Res 2000;87:214-20.